Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Sep 3, 2026 · 4:00 PM EDT

Revium Rx (RVRC) Prepaid Assets (2024 - 2026)

Revium Rx's (RVRC) quarterly Prepaid Assets came in at $341000.0 in Q2 2026, down 9.07% quarter-over-quarter from $375000.0 in Q4 2025.

Analysis

Revium Rx (RVRC) Prepaid Assets (2024 - 2026) Analysis & Trends

Revium Rx has disclosed Prepaid Assets across 3 years of filings, most recently posting $341000.0 for Q2 2026.

  • In Q2 2026, Prepaid Assets changed N/A year-over-year to $341000.0; the TTM figure through Jun 2026 stood at $341000.0 (changed N/A YoY), while the FY2025 annual figure was $375000.0, up 57.56% from the prior year.
  • Prepaid Assets came in at $341000.0 for Q2 2026 at Revium Rx, down from $375000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $375000.0 in Q4 2025 to a low of $238000.0 in Q4 2024.
  • Average Prepaid Assets over 3 years is $318000.0, with a median of $341000.0 recorded in 2026.
  • The largest YoY upside for Prepaid Assets was 57.56% in 2025 against a maximum downside of 57.56% in 2025.
  • Over 3 years, Prepaid Assets stood at $238000.0 in 2024, then soared by 57.56% to $375000.0 in 2025, then slipped by 9.07% to $341000.0 in 2026.
  • Per Business Quant data, the three most recent Prepaid Assets figures were $341000.0 in Q2 2026, $375000.0 in Q4 2025, and $238000.0 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Revium Rx 86.84 Mn 85.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 341,000.00
Dec 31, 2025 375,000.00
Dec 31, 2024 238,000.00